Share

Investor Information

Johnson & Johnson to Participate in the 41^st Annual J.P. Morgan Healthcare Conference

Johnson & Johnson to Participate in the 41^st Annual J.P. Morgan Healthcare Conference

Learn More
Johnson & Johnson to Acquire Abiomed

Johnson & Johnson Hosts Investor Conference Call on Third-Quarter Results

Listen to Webcast: Morgan Stanley 20^th Annual Global Healthcare Conference
NYSE: JNJ $175.74 -$1.46 (-0.820%)
- Day High $177.89
- Day Low $175.66
- Volume 4,560,968
Last Updated: 12/09/2022 04.10 PM

2022 Annual Meeting of Shareholders

2022 Annual Meeting of Shareholders

Annual Meeting Materials and Webcast

2022 ESG Investor Update Webcast

2022 ESG Investor Update Webcast

Learn More

Latest News Releases

Latest News

December 08, 2022

Johnson & Johnson to Participate in the 41^st Annual J.P. Morgan Healthcare Conference
Latest News

November 30, 2022

Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
Media Statement

November 15, 2022

Johnson & Johnson Rises to #2 in Ranking of Companies’ Efforts to Expand Access to Medicines Worldwide

See All News Releases

Webcast: Pharmaceutical Business Review 2021

Webcast: Pharmaceutical Business Review 2021

2021 Health for Humanity Report

2021 Health for Humanity Report

2021 Janssen U.S. Transparency Report

2021 Janssen U.S. Transparency Report

2021 Annual Report

2021 Annual Report

Investor Relations

Quarterly Results

See the latest quarterly sales and earnings from Johnson & Johnson, as well as historical results covering the past ten years.

Learn More
Shareholder Tools
- Email Alerts Subscription
- RSS News Feeds

Investor FAQs

Answers to common questions regarding purchasing and owning Johnson & Johnson stock.

Learn More

ESG Resources

Effective management of ESG matters is a business imperative.

Learn More

Contact Investor Relations

Questions? Please contact Investor Relations: